 |
市場調查報告書
商品編碼
1983216
醫用食品市場：按產品類型、治療應用、分銷管道和地區分類Rx Medical Food Market, By Product Type, By Therapeutic Application, By Distribution Channel, By Geography |
||||||
預計到2026年，醫用食品市場規模將達到289.275億美元，2033年將達到467.118億美元。預計從2026年到2033年，其複合年成長率將達到7.1%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 289.275億美元 |
| 歷史數據時期： | 2020-2024 | 預測期： | 2026-2033 |
| 2026-2033年預測期間的複合年成長率： | 7.10% | 2033年市場規模預測： | 467.118億美元 |
醫用食品（FDA）是一類用於特定疾病和病症（例如肺部疾病、胃腸道疾病和代謝紊亂）的膳食管理和預防治療的食品。 FDA食品中使用的成分必須具有「公認安全（GRAS）」認證。 FDA食品不同於膳食補充劑、維生素和處方藥。 FDA食品以蛋白質和營養素（如Omega-3脂肪酸、螯合鋅、異黃酮）為基礎，並可能含有葉酸和硫胺素等礦物質和維生素。這些產品需由醫生開立處方或在醫生指導下服用。美國食品藥物管理局（ FDA）將FDA食品分為四大類：營養全面的產品、營養不全面的產品、代謝失調配方、口服補液鹽。 FDA也根據《孤兒藥法案》（1988年）對FDA食品進行單獨監管，以確保公眾安全並防止銷售虛假宣稱可以治癒疾病的產品。用於醫療用途的食品無需獲得上市前核准、臨床實驗藥物（IND）認定或向美國食品藥物管理局（FDA）進行單獨註冊。但是，所有健康益處聲明都必須有相應的實驗室和臨床試驗來支持。
市場動態
預計在預測期內，加強有機策略，例如各監管機構之間的合作，將推動全球處方箋食品市場的發展。例如，2021年10月，印度食品安全標準局（FSSAI）與印度食品加工工業部（MoFPI）簽署協議，支持農民組織（FPO）、微型食品企業、自助團體（SHG）和生產者合作社提升其食品業務標準。該協議涵蓋食品安全培訓以及微企業的註冊和許可。 FSSAI和MoFPI正在協助微企業取得FSSAI頒發的許可證和註冊。
本次調查的主要特點。
- 本報告對全球醫用食品市場進行了詳細分析，以 2021 年為基準年，展示了預測期（2022-2030 年）的市場規模和複合年成長率（%）。
- 本報告指出了各個細分市場的潛在商機，並說明了該市場中具有吸引力的投資提案矩陣。
- 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
- 本報告根據以下參數介紹了全球處方箋醫用食品市場的主要企業概況：公司概況、產品系列、主要亮點、財務表現和策略。
- 透過利用本報告中提出的見解，企業行銷負責人和經營團隊可以就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
- 本報告面向該產業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 透過分析全球處方箋食品市場時所使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。
目錄
第1章：研究目標與前提條件
- 研究目標
- 前提
- 簡稱
第2章 市場範圍
- 報告摘要
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章：市場動態、監管與趨勢分析
- 市場動態
- 促進因素
- 阻礙因素
- 市場機遇
- 影響分析
- 市場趨勢
- 近期趨勢
- 收購與合作情景
- 技術概述
- 法規環境
- 價格分析
- PEST分析
第4章 全球醫用食品市場：依產品類型分類，2026-2033年
- 概述
- 藥片
- 粉末
- 液體
- 其他（威化餅、咀嚼片、能量棒）
第5章 全球醫用食品市場：依治療應用分類，2026-2033年
- 概述
- 疼痛管理
- 神經系統疾病
- 消化器官系統疾病
- 呼吸系統疾病
- 代謝性疾病
- 其他情況（纖維化、透析、愛滋病等）
第6章 全球醫用食品市場：依通路分類，2026-2033年
- 概述
- 零售藥房
- 網路藥房
第7章 全球醫用食品市場：依地區分類，2026-2033年
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 亞太其他地區
- 中東
- GCC
- 以色列
- 其他中東國家
- 非洲
- 北非
- 中非
- 南非
第8章 競爭情勢
- Abbott Laboratories
- Danone SA
- Mead Johnson &Company, LLC.
- Fresenius Kabi AG
- Nestle SA
- Primus Pharmaceuticals, Inc.
- Targeted Medical Pharma Inc.
- Pivotal Therapeutics Inc.
- VAYA Pharma, Inc.
- Lanfam
- AlfaSigma SPA
第9章
- 調查方法
- 關於本公司
Rx Medical Food Market is estimated to be valued at USD 28,927.5 Mn in 2026 and is expected to reach USD 46,711.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 28,927.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.10% | 2033 Value Projection: | USD 46,711.8 Mn |
Medical food is a category of food products for dietary management or preventive therapy for specific disease or medical conditions such as pulmonary, gastrointestinal, and metabolic disorders. Ingredients used in medical foods must have 'generally recognized as safe' (GRAS) status. Medical food is different from nutritional food, dietary supplements, and prescription drugs. Medical food is protein-based, nutrient-based (Omega 3 fatty acids, chelated zinc, and isoflavones), and may contain minerals and vitamins such as folic acid and thiamine. These products are prescribed by physicians or taken under their supervision. The U.S. Food & Drug Administration (FDA) has classified medical foods into four major categories; nutritionally complete products, nutritionally incomplete products, formulas for metabolic disorders, and oral rehydration solutions. The U.S. Food and Drug Administration separately regulates medical food under Orphan Drug Act (1988) to ensure safety of populace and curb presence of products falsely claiming to cure medical conditions. Medical food does not require premarket approval, specification as an investigational new drug (IND), and individual registration with the FDA. However, they are required to support all their health claims with proper laboratory and clinical studies.
Market Dynamics
Increasing number of organic strategies such as collaboration by the various regulatory authorities is expected to drive the global Rx medical food market over the forecast period. For instance, in October 2021, Food Safety and Standards Authority of India (FSSAI) had signed an agreement with Ministry of Food Processing Industries (MoFPI) to support Farmer Producer Organizations (FPOs), Micro Level Food Entrepreneurs, Self Help Groups (SHGs) and Producers Cooperatives to improve the standards of their food business. This agreement will include food safety training and Registration & License of the Micro Enterprises. FSSAI and MoFPI support micro enterprises for obtaining FSSAI license and registration.
Key features of the study
- This report provides an in-depth analysis of the global Rx medical food market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global Rx medical food market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abbott Laboratories, Danone S.A., Mead Johnson & Company, LLC, Fresenius Kabi AG, Nestle S.A., Primus Pharmaceuticals, Inc., Targeted Medical Pharma Inc., Pivotal Therapeutics Inc., VAYA Pharma, Inc., Lanfam and AlfaSigma S.P.A.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global Rx medical food market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Rx medical food market
Market Segmentation
- By Product Type
- Pills
- Powder
- Liquid
- Others (Wafers, Chewable, and Bars)
- By Therapeutic Application
- Pain Management
- Neurological Disorders
- Gastrointestinal Disorders
- Pulmonary Disorders
- Metabolic Disorders
- Others (Fibrosis, Dialysis, AIDS, etc.)
- By Distribution Channel
- Retail Pharmacies
- Online Pharmacies
- By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players
- Abbott Laboratories
- Danone S.A.
- Mead Johnson & Company, LLC
- Fresenius Kabi AG
- Nestle S.A.
- Primus Pharmaceuticals, Inc.
- Targeted Medical Pharma Inc.
- Pivotal Therapeutics Inc.
- VAYA Pharma, Inc.
- Lanfam
- AlfaSigma S.P.A.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Therapeutic Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- Pricing Analysis
- PEST Analysis
4. Global Rx Medical Food Market, By Product Type, 2026 - 2033, (USD Mn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Pills
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Powder
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Liquid
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Others (Wafers, Chewable, and Bars)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
5. Global Rx Medical Food Market, By Therapeutic Application, 2026 - 2033, (USD Mn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Pain Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Neurological Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Gastrointestinal Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Pulmonary Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Metabolic Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Others (Fibrosis, Dialysis, AIDS, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
6. Global Rx Medical Food Market, By Distribution Channel, 2026 - 2033, (USD Mn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
7. Global Rx Medical Food Market, By Region, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application , 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Danone S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mead Johnson & Company, LLC.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Fresenius Kabi AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Nestle S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Primus Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Targeted Medical Pharma Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pivotal Therapeutics Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- VAYA Pharma, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lanfam
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AlfaSigma S.P.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
